Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Surgery|August 1, 1995
Antitumor activity of three mouse mammary cancer cell lines after interferon-gamma gene transfectionY L Matory, M Chen, D M Dorfman, et al.International Journal of Cancer|September 15, 1990
ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysisE Braakman, P S Goedegebuure, R J Vreugdenhil, et al.Journal of Leukocyte Biology|April 20, 2001
Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytesH G Joo, P S Goedegebuure, N Sadanaga, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
Local secretion of IFN-gamma induces an antitumor response: comparison between T cells plus IL-2 and IFN-gamma transfected tumor cellsN Sadanaga, M Nagoshi, J A Lederer, et al.Proceedings of the National Academy of Sciences of the United States of America|January 17, 1995
Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptideG E Peoples, P S Goedegebuure, R Smith, et al.European Journal of Immunology|May 1, 1997
The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytesM Peiper, P S Goedegebuure, D C Linehan, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytesM Nagoshi, P S Goedegebuure, U L Burger, et al.International Journal of Cancer|October 21, 1993
The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitroD D Schoof, J A Obando, J C Cusack, et al.Cellular Immunology|June 1, 1994
Classification of CD4+ T helper cell clones in human melanomaP S Goedegebuure, K Y Lee, Y L Matory, et al.Cellular Immunology|September 1, 1995
Shared T cell epitopes in epithelial tumorsG E Peoples, R C Smith, D C Linehan, et al.Pageof 5